Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients

被引:77
作者
Bubber, P.
Hartounian, V. [2 ,3 ]
Gibson, G. E. [1 ]
Blass, J. P.
机构
[1] Cornell Univ, Weill Cornell Med Sch, Burke Med Res Inst, Weill Med Coll, White Plains, NY 10605 USA
[2] Mt Sinai Sch Med, New York, NY USA
[3] Bronx Vet Affairs Med Ctr, MIRECC, Bronx, NY 10468 USA
关键词
Mitochondria; Tricarboxylic acid cycle; Energy metabolism; Postmortem interval; Schizophrenia; ALPHA-KETOGLUTARATE DEHYDROGENASE; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GLUCOSE-TOLERANCE; PREFRONTAL CORTEX; ENZYMES; METABOLISM; COMPLEX; GLYCOLYSIS;
D O I
10.1016/j.euroneuro.2010.10.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Images of brain metabolism and measurements of activities of components of the electron transport chain support earlier studies that suggest that brain glucose oxidation is inherently abnormal in a significant proportion of persons with schizophrenia. Therefore, we measured the activities of enzymes of the tricarboxylic (TCA) cycle in dorsolateral-prefrontal-cortex from schizophrenia patients (N=13) and non-psychiatric disease controls (N=13): the pyruvate dehydrogenase complex (PDHC), citrate synthase (CS), aconitase, isocitrate dehydrogenase (ICDH), the alpha-ketoglutarate dehydrogenase complex (KGDHC), succinate thiokinase (STH), succinate dehydrogenase (SDH), fumarase and malate dehydrogenase (MDH). Activities of aconitase (18.4%, p<0.05), KGDHC (26%) and STH (28.2%, p<0.05), enzymes in the first half of the TCA cycle, were lower, but SDH (18.3%, p<0.05) and MDH (34%, p<0.005), enzymes in the second half, were higher than controls. PDHC, CS, ICDH and fumarase activities were unchanged. There were no significant correlations between enzymes of TCA cycle and cognitive function, age or choline acetyl transferase activity, except for aconitase activity which decreased slightly with age (r = 0.55, p = 003). The increased activities of dehydrogenases in the second half of the TCA cycle may reflect a compensatory response to reduced activities of enzymes in the first half. Such alterations in the components of TCA cycle are adequate to alter the rate of brain metabolism. These results are consistent with the imaging studies of hypometabolism in schizophrenia. They suggest that deficiencies in mitochondrial enzymes can be associated with mental disease that takes the form of schizophrenia. (C) 2010 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:254 / 260
页数:7
相关论文
共 50 条
[1]   Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder [J].
Andreazza, Ana C. ;
Shao, Li ;
Wang, Jun-Feng ;
Young, L. Trevor .
ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (04) :360-368
[2]  
[Anonymous], 2000, NEUROBIOL AGING, DOI DOI 10.1016/S0197-4580(00)82590-7
[3]   Purification and stabilization of a monomeric isocitrate dehydrogenase from Corynebacterium glutamicum [J].
Bai, C ;
Fernandez, E ;
Yang, H ;
Chen, RD .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 15 (03) :344-348
[4]   Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine [J].
Ben-Shachar, D .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (06) :1241-1251
[5]  
BERMAN KF, 1992, ARCH GEN PSYCHIAT, V49, P927
[6]   The role of the metabolic lesion in Alzheimer's disease [J].
Blass, John P. ;
Gibson, Gary E. ;
Hoyer, Siegfried .
JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (03) :225-232
[7]   Mitochondrial involvement in Alzheimer's disease [J].
Bonilla, E ;
Tanji, K ;
Hirano, M ;
Vu, TH ;
DiMauro, S ;
Schon, EA .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02) :171-182
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   Mitochondrial enzymes in schizophrenia [J].
Bubber, P ;
Tang, JC ;
Haroutunian, V ;
Xu, H ;
Davis, KL ;
Blass, JP ;
Gibson, GE .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (02) :315-321
[10]   A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia [J].
Clark, D ;
Dedova, I ;
Cordwell, S ;
Matsumoto, I .
MOLECULAR PSYCHIATRY, 2006, 11 (05) :459-470